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Systemic lupus erythematosus is an autoimmune disease
characterized by the presence of autoantibodies and by
lymphocytic infiltration into lesions at several sites such
as skin, kidney, and other organs. Immunohistologic
studies have clarified that the majority of lymphocytes
in the skin are CD4F ab T cells. In the present work, to
clarify the pathologic role of T cells in the skin of systemic
lupus erythematosus patients, we analyzed T cell receptor
(TCR) clonotypes of T cells infiltrating into skin lesions.
TCR Vb gene transcripts from T cells from discoid
lesions of the skin and peripheral blood lymphocytes of
four systemic lupus erythematosus patients were ampli-
fied by reverse transcriptase polymerase chain reaction.
Southern blot analysis of polymerase chain reaction
product demonstrated the heterogeneous TCR Vb reper-
toire of T cells in the skin of systemic lupus eryth-
ematosus. Single-strand conformation polymorphism
Systemic lupus erythematosus (SLE) is a potentially seriousautoimmune disease characterized by a broad diversity ofclinical features and autoantibodies. B cells that produceantoantibodies seem to be selected by autoantigens andsubsequent somatic mutation of IgV regions (Shlomchik
et al, 1987, 1990; Van Es et al, 1991). The production of autoantibodies
is supported by helper T cells (Takeuchi et al, 1984; Morris et al, 1990).
In contrast, T cells infiltrate into various organs such as skin (Clark
et al, 1973; Gilliam and Sontheimer, 1982), kidney (D’Agati et al,
1986), lung (Matthay et al, 1975), and gastrointestinal tract (Nadorra
et al, 1987), where they may function as auto-reactive T cells, resulting
in autoimmunity. In the skin lesions of SLE patients, which is a
common clinical manifestation, CD41 αβ T cells infiltrate the papillary
dermis and induce degeneration and vacuolization of the basal region
(Clark et al, 1973; Gilliam and Sontheimer, 1982). Thus, T cells in
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analysis showed several distinct bands for smears of most
TCR Vb genes from T cells infiltrating the skin, whereas
smears with few bands were found for all TCR Vb genes
from peripheral blood lymphocytes of the same patients.
The number of bands encoding each TCR Vb gene
from the skin was significantly higher compared with
peripheral blood lymphocytes. Sequencing analysis
showed a Leucine-X-Glycine amino acid motif at position
96–98 in the CDR3 region at the frequency of 23–24% in
skin-accumulated T cells from two patients, whereas the
frequency of this motif in peripheral T cells was only 0–
3%, indicating limited T cell epitopes. In conclusion, T
cells infiltrating into the skin of systemic lupus ery-
thematosus patients might recognize restricted T cell
epitopes on autoantigens and trigger the autoimmune
reaction in skin lesions. Key words: autoantigens/clonal
expansion/epitopes/single-strand conformation polymorphism.
J Invest Dermatol 110:41–46, 1998
the skin appear to be a pathogenic factor in the generation of skin
lesions in SLE.
Recently, it has been reported that biased T lymphocytes appear to
play an important role in disease development in cases of some organ-
specific autoimmune diseases such as multiple sclerosis (Oksenberg
et al, 1990; Ben-Nun et al, 1991; Kotzin et al, 1991), rheumatoid
arthritis (Palliard et al, 1991; Sottini et al, 1991; Uematsu et al, 1991),
Sjo¨gren’s syndrome (Sumida et al, 1992; Yonaha et al, 1992; Murata
et al, 1995; Matsumoto et al, 1996), and systemic sclerosis (Sumida
et al, 1995). In SLE, restriction fragment length polymorphism studies
revealed an association between one framework gene encoding the
constant (C) region of the T cell receptor (TCR) α chain and SLE
(Tebib et al, 1990). Recently, it was reported that the TCR Vα8 gene
family is predominantly used in T helper cell lines from SLE patients
(Desai-Mehta et al, 1995). Olive et al (1994) reported that Vδ1 and
Vδ2 genes are preferentially rearranged, whereas Vγ repertoires in SLE
are diverse. These observations suggest that restricted T cells might
play a crucial role in systemic autoimmune diseases such as SLE.
In this study, to address the questions of whether the TCR repertoire
of infiltrating T cells in the skin lesions of patients with SLE is restricted
and whether these cells expand by antigen stimulation, we analyzed
the TCR Vβ gene and TCR clonotypes of infiltrating T cells using
polymerase chain reaction (PCR)-Southern blot analysis and subsequent
single-strand conformation polymorphism (SSCP) analysis. We obtained
evidence that the TCR Vβ repertoire is not limited, but that T
cells accumulate clonally in skin lesions, indicating antigen-driven
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stimulation. Sequencing analysis on skin-specific TCR Vβ genes
showed that a Leucine-X-Glycine (LXG) amino acid sequence motif
occured preferentially at position 96–98 in the complementarity
determining region 3 (CDR3) at the frequency of 23–24% in two of
four patients examined, whereas the frequency was only 3% in TCR
clones encoding the same Vβ family genes from peripheral blood
lymphocytes (PBL). These findings suggest relatively limited T cell
epitopes. Possible mechanisms for the progression of SLE are discussed.
MATERIALS AND METHODS
Patients and skin biopsies Four patients with SLE were referred to Chiba
University Hospital or Keio University Hospital; all met the criteria for a
diagnosis of SLE (Tan et al, 1982). All patients were of Japanese ancestry and
had skin lesions. None of the patients were related. All four patients had not
received treatment, including corticosteroids, in the past. All patients were
thought to be ‘‘active’’ because serum complement levels were decreased and
anti-DNA antibodies were elevated. Patient LE-2 and LE-4 showed proteinuria.
The types of skin lesions that were biopsied from all patients were discoid
lesions. The biopsy samples that were obtained from lesional skin included
lymphocytic infiltration in all patients. Four disease-free subjects were also
examined as controls. The skin biopsy samples did not include lymphocytic
infiltration except for a few lymphocytes in control subjects. Typing of the
human histocompatibility leukocyte antigens (HLA)-DR and -DQ alleles was
performed by PCR combined with dot-blot hybridization with sequence-
specific oligonucleotide probes following the protocol of the Eleventh Histoc-
ompatibility Workshop (Sumida et al, 1994).
Histologic and immunohistochemical examination Skin biopsy samples
were stained with hematoxylin and eosin for histologic examination. For
immunohistologic examination, a portion of a sample was snap frozen, and
cryostat sections were cut and stained with anti-CD4 and anti-CD8 monoclonal
antibodies (Becton Dickinson, Mountain View, CA). Cryostat sections were
incubated with biotinylated rabbit anti-mouse immunoglobulins (Dako, Copen-
hagen, Denmark), then with streptABComplex/HRP (Dako), and finally with
a peroxidase substrate.
Preparation of RNA and PCR Total RNA (5–10 µg) from skin specimens
and PBL of four SLE patients and four healthy subjects was prepared using
Isogen solution (Nippon Gene, Tokyo, Japan). The first strand complementary
DNA (cDNA) was synthesized in a 20 µl reaction mixture from 5 µg of total
RNA using a cDNA synthesis module (Amersham International, Buckingham-
shire, U.K.). Amplification was performed with Taq polymerase in 50 µl of
standard buffer using 0.2 µl of cDNA (corresponding to 50 ng of total RNA)
with 20 different Vβ and Cβ primers to detect each Vβ gene. The sequences
of the Vβ and Cβ primers were obtained from previously published data
(Sumida et al, 1992). Oligonucleotides were synthesized with a DNA synthesizer
(Applied Biosystems, Foster City, CA). The denaturing step was carried out at
95°C for 1.5 min, the annealing step at 60°C for 1 min, and the extension step
at 72°C for 1 min for 30 cycles on a DNA thermal cycler (Perkin-Elmer,
Norwalk, CT). One-fifth of the PCR product was subjected to 2% agarose gel
electrophoresis and hybridized with a 32P-labeled Pst I fragment of the JUR-β
gene (Cβ) probe (Sumida et al, 1992).
SSCP analysis Amplified DNA was diluted (1:2) in a denaturing solution
(95% formamide, 10 mM ethylenediamine tetraacetic acid, 0.1% bromophenol
blue, 0.1% xylene cyanol) and incubated at 90°C for 2 min. The diluted sample
(6 µl) was electrophoresed in nondenaturing 5% polyacrylamide gels containing
10% glycerol to discriminate the three-dimensional conformations of the
amplified TCR Vβ genes (Yamamoto et al, 1992). The gel was run at 35 W
constant power for 2.5 h. After electrophoresis, the DNA was transferred
to Immobilon-S (Millipore Intertech, Bedford, MA) and hybridized with
biotinylated Cβ probe (59-A(AC)AA(GC)GTGTTCCCACCCGAGGTCGC-
TGTGTT-39). The DNA was then visualized with a Phototope detection kit
(New England Biolabs, Beverly, MA).
Sequencing of cDNA encoding the TCR Vb genes Complementary
DNA encoding the TCR genes from clonally expanded T cells in the skin
were eluted from the SSCP gels and amplified by secondary PCR using inside
primers with an EcoRI enzyme site sensitive for each Vβ gene. The sequences
of the Vβ and Cβ inside primers were as follows:
Vβ1 (59-TCTAGAATTCGATTCTCCGCACAACAGT-39)
Vβ2 (59-TCTAGAATTCAGAAGGACAAGTTTCTCA-39)
Vβ4 (59-TCTAGAATTCTTGACAAGTTTCCCATCA-39)
Vβ5 (59-TCTAGAATTCTTCTCAGGGCGCCAGTTC-39)
Vβ6 (59-TCTAGAATTCCGGTTCTTTGCAGTCAGG-39)
Vβ7 (59-TCTAGAATTCCCTGAATGCCCCAACAGC-39)
Vβ8 (59-TCTAGAATTCGATTCTCAGCTAAGATGC-39)
Vβ12 (59-TCTAGAATTCCTCTAGATCAAAGACAGAGG-39)
Vβ13.1 (59-TCTAGAATTCACAGAGGATTTCCCGCTC-39)
Vβ13.2 (59-TCTAGAATTCCAGAATTTCCTGCTGGGG-39)
Vβ14 (59-TCTAGAATTCCTCTCGAAAAGAGAAGAGGA-39)
Vβ15 (59-TCTAGAATTCTACAGTGTCTCTCGACAG-39)
Vβ17 (59-TCTAGAATTCAGCGTCTCTCGGGAGAAG-39)
Vβ19 (59-TCTAGAATTCCTCAATGCCCCAAGAACGC-39)
Cβ (59-TCTAGAATTCAGCGACCTCGGGTGGGAA-39)
Oligonucleotides were synthesized with a DNA synthesizer (Applied Bio-
systems). PCR products were purified by phenol extraction, precipitated with
ethanol, and digested with excess amounts of EcoRI. The DNA fragments
were ligated to M13 mp19 phage vectors obtained by EcoRI digestion. Phages
were grown on TG-1 Escherichia coli cells. After hybridization with a Cβ probe,
a single phage was allowed to grow, and recombinant phage DNA was purified
for DNA sequence determination. Three different plaques encoding TCR
genes from one band on SSCP gel were sequenced independently and
these DNA showed the identical TCR sequence. Sequencing reactions were
performed by automated sequencing (Applied Biosystems).
Statistical analysis Statistical analysis of the results was carried out by the
unpaired t test.
RESULTS
CD4F T cells infiltrate the skin of patients with SLE Histologic
examination (hematoxylin and eosin staining) of skin lesions of patients
with SLE was performed. The epidermal basal layer showed focal
liquefaction degeneration. Lymphocytic infiltration was observed in
the upper dermis, periappendageal, and perivascular areas. Immuno-
histochemical studies using monoclonal antibodies against CD4 or
CD8 confirmed that the majority of infiltrating lymphocytes in skin
were CD41 T cells. The HLA-DR and DQ typing of the individual
patients was performed (data not shown). HLA-DR2 (DRB1*1502,
DRB1*1602, DRB5*0102, and DRB5*02) was found in all patients.
Patient LE-3 is an HLA-DR2/DR4 heterozygote. In two patients
(LE-1 and LE-4), DRB3*0202 was found.
The TCR Vb repertoire of T cells in the skin is
heterogeneous To analyze the mechanism of skin manifestations in
patients with SLE, we examined the TCR repertoire of infiltrating T
cells in the skin using the family PCR method (Fig 1). Four skin
biopsy specimens from four SLE patients with skin manifestations were
analyzed. As control, four PBL samples from the same individuals were
used. Most TCR Vβ genes on T cells were detected in the skin,
whereas all TCR Vβ genes were detected in PBL. These results suggest
that the TCR Vβ repertoire of T cells in the skin is heterogenous as
well as PBL and there were no common predominant Vβ genes.
The number of accumulated T cell clonotypes in skin lesions
was higher than peripheral blood from patients with SLE To
analyze T cell clonotypes in the skin lesions from patients with SLE,
TCR Vβ clonotypes in the skin and on PBL of four SLE patients
were examined by the PCR-SSCP method. Figure 2 shows several
distinct bands in most Vβ genes from T cells infiltrating the skin,
whereas smear was found for all Vβ genes from PBL. As shown in
Table I, the numbers of bands encoding TCR Vβ genes from skin
lesions (5.3 6 0.7, 5.7 6 1.0, 7.4 6 1.2, and 6.4 6 1.0; means
6 SEM) were significantly higher (p , 0.001) in all of four SLE
patients compared with PBL (2.5 6 0.4, 1.8 6 0.3, 3.2 6 0.4, and
2.8 6 0.4). The numbers of T-cell clones expressing the TCR Vβ1,
Vβ2, Vβ4, Vβ5, Vβ7, Vβ12, and Vβ13 genes (6.5 6 0.5, 10.3 6 1.7,
8.3 6 0.7, 7.0 6 0.6, 6.3 6 0.3, 7.5 6 0.5, and 11.5 6 2.2) were
specifically increased in the skin compared with PBL (1.8 6 0.6,
2.3 6 0.3, 1.5 6 1.0, 3.8 6 0.5, 3.5 6 0.3, 3.3 6 0.7, and 4.3 6 0.6)
(p , 0.05 to p , 0.005). These results suggest that some T cells in
skin lesions of SLE patients expand clonally, indicating antigen stimula-
tion. In contrast, the numbers of bands from skin in all four healthy
subjects (Table II; 4.2 6 1.0, 3.3 6 0.7, 4.5 6 0.9, and 5.3 6 0.8)
were not significantly higher compared with PBL (2.3 6 0.6, 2.8 6 0.6,
4.7 6 0.8, and 3.3 6 0.7). The number of bands from skin in SLE
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Figure 1. The TCR Vb repertoire of T cells in the skin is heterogeneous.
Family PCR-Southern blot analysis of TCR Vβ genes on T cells infiltrating
the skin of patients with SLE. The expression of TCR Vβ genes on T cells in
PBL (upper) or skin (lower) from four SLE patients (a, LE-1; b, LE-2; c, LE-3;
d, LE-4). Gene expression was detected in most Vβ genes in the skin.
patients (6.1 6 0.5) was significantly higher than that in healthy
subjects (4.4 6 0.4) (p , 0.01).
Some conserved amino acid sequence motifs in CDR3 of TCR
b genes from SLE skin-specific T cells As shown in Fig 2 and
Table I, several T cell clones accumulate in the skin but not in
peripheral blood. We selected skin-specific T cell clones on SSCP gel
in Fig 2 and DNA encoding the TCR genes from the skin-specific
bands were eluted from the gels and sequenced. To examine the amino
acid sequences of the TCR Vβ region of these skin-specific T cell
clones, DNA-encoding TCR genes were eluted from the skin-specific
bands on SSCP and sequenced. Three different plaques encoding TCR
genes from one band on SSCP gel were sequenced independently and
these DNA showed the identical TCR sequence. In one patient
(LE-1), the numbers of T cell clones expressing TCR Vβ4, Vβ5,
Vβ13, and Vβ19 genes (9, 7, 13, and 5) in the skin were specifically
Figure 2. Several T cell clonotypes accumulate in skin of patients with
SLE. TCR Vβ clonotypes of infiltrating T cells in the skin and PBL of patients
with SLE using the PCR-SSCP method. To analyze T cell clonotypes in the
skin lesions of patients with SLE, TCR Vβ clonotypes in the skin lesions and
PBL of four SLE patients were examined by the PCR-SSCP method (a, LE-1;
b, LE-2; c, LE-3; d, LE-4). PCR-SSCP analysis showed several distinct bands
for most Vβ genes from T cells infiltrating the skin lesions, whereas smear was
found for all Vβ genes from PBL of SLE patients.
increased in comparison with PBL (0, 3, 4, and 0) and there were no
identical TCR in skin and PBL. As shown in Table III, an LXG
amino acid sequence motif was found at position 96–98 in CDR3 for
five of 21 clones (24%). Leucine (L) was conserved at position 96 or
97 in seven of 21 (33%). In another patient (LE-4), the numbers of T
cell clones expressing TCR Vβ2, Vβ5, Vβ6, and Vβ13 genes (7, 8,
10, and 8) in the skin were increased in comparison with the numbers
in PBL (3, 3, 2, and 6), and there were no identical TCR between
skin and PBL. An LXG sequence motif was also found in position
96–98 at a frequency of 23%. Leucine was conserved at position 96
or 97 in seven of 13 clones (54%). In the other two patients (LE-2
and LE-3) there was no conserved amino acid sequence motif in
CDR3 on skin-specific T cells. Contrary to SLE patients, the LXG
sequence motif (position 96–98) was not found in the skin from all of
four healthy subjects (data not shown). In healthy subjects, leucine at
position 96 or 97 on skin-specific T cells was found in two of 13
clones (15%) (Control 1), two of eight clones (25%) (Control 2), two
of nine clones (22%) (Control 3), and one of 11 clones (9%) (Control
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Table I. Numbers of accumulated clonotypes of TCR Vb genes in T cells from patients with SLE
Vβ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 means
6 SEM
LE-1 PBL 3 2 3 0 3 6 4 0 2 2 2 4 4 4 3 0 3 4 0 0 2.5 6 0.4
skin 6 –e – 9 7 3 6 5 2 3 4 7 13 4 3 – 5 3 5 5 5.360.7d
LE-2 PBL 0 – 1 0 4 1 3 2 3 4 2 – 3 2 0 – 1 3 1 0 1.8 6 0.3
skin – 12 3 – – 6 6 3 4 2 – – 8 5 3 – 11 – – – 5.761.0d
LE-3 PBL 2 2 3 2 5 6 4 6 6 4 1 2 4 5 3 0 3 3 2 1 3.2 6 0.4
skin – 12 – 9 6 7 7 8 – 1 – 8 17 8 – – 4 – 2 – 7.461.2d
LE-4 PBL 2 3 2 4 3 2 3 1 2 4 1 4 6 6 2 0 4 4 1 1 2.8 6 0.4
skin 7 7 – 7 8 10 – 2 4 4 – – 8 12 – – – – – 1 6.461.0d
Mean PBL 1.8 2.3 2.3 1.5 3.8 3.8 3.5 2.3 3.3 3.5 1.5 3.3 4.3 4.3 2.0 0.0 2.8 3.5 1.0 0.5
skin 6.5b 10.3b 3.0 8.3c 7.0b 6.5 6.3c 4.5 3.3 2.5 4.0 7.5a 11.5a 7.3 3.0 – 6.7 3.0 3.5 3.0
a p , 0.05.
b p , 0.01.
c p , 0.005.
d p , 0.001.
e Neither smear nor distinct bands are detected.
Table II. Numbers of accumulated clonotypes of TCR Vβ genes in T cells from healthy subjects
Vβ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 means
6 SEM
Cont-1 PBL 4 1 0 5 1 1 4 8 4 3 1 4 0 1 0 –a 0 – – – 2.3 6 0.6
skin 4 3 0 2 – 1 4 11 4 1 – 7 1 9 – – 8 – – – 4.2 6 1.0
Cont-2 PBL 4 – 0 0 2 2 2 9 4 2 1 4 2 6 0 – 5 2 – 1 2.8 6 0.6
skin 5 1 1 3 – – 2 9 2 1 2 7 – 4 – – 3 – – – 3.3 6 0.7
Cont-3 PBL 7 0 7 5 1 – 8 8 7 – – 4 0 8 3 – 7 1 – – 4.7 6 0.8
skin 8 – 3 9 1 – 8 8 5 2 1 5 0 8 0 – 8 1 – – 4.5 6 0.9
Cont-4 PBL 5 – 0 3 1 – 1 8 2 2 1 5 6 2 – – 7 3 – – 3.3 6 0.7
skin 7 1 4 7 2 1 11 8 6 4 – 7 0 8 – – 8 – – – 5.3 6 0.8
Mean PBL 5.0 0.5 1.8 3.3 1.3 1.0 3.8 8.3 4.3 2.3 1.0 4.3 2.0 4.3 1.0 – 4.8 2.0 – 1.0
skin 6.0 1.7 2.0 5.3 1.5 1.3 6.3 9.0 4.3 2.0 1.5 6.5b 0.3 7.3 0.0 – 6.8 1.0 – 3.0
a Neither smear nor distinct bands are detected.
b p , 0.01.
4). The LXG sequence motif (position 96–98) and leucine at position
96 or 97 were found at higher frequency in the SLE skin (LE-1 and
LE-4) than in normal skin. To analyze whether the LXG amino acid
sequence motif in CDR3 is specific to the skin, cDNA encoding TCR
Vβ genes from PBL of two patients (LE-1 and LE-4) were cloned and
sequenced (data not shown). An LXG sequence motif in CDR3 was
found in only one of 36 clones (2.8%) (LE-1) or none of 19 clones
(0%) (LE-4). Leucine at position 96 or 97 was found in only four of
36 clones (11%) (LE-1) or two of 19 clones (11%) (LE-4). The LXG
sequence motif (position 96–98) and leucine at position 96 or 97 were
found at high frequency in the skin from these patients (LE-1 and
LE-4). These results suggest that T cells that infiltrate the skin might
recognize relatively limited epitopes on the autoantigen in skin.
DISCUSSION
Activated T cells have been detected in the peripheral blood of SLE
patients (Alocer-Varela et al, 1991) and may mediate B cell autoantibody
production (Shivakumar et al, 1989; Rajagopalan et al, 1990; Murakami
et al, 1992). The production of pathogenic autoantibodies is driven by
certain helper T (Th) cells that are detectable in patients with active
lupus, but not in normal subjects or lupus patients in remission
(Shivakumar et al, 1989). The majority of these cells are CD41 αβ
Th cells and some are double negative αβ T cells (Shivakumar et al,
1989; Linker-Israeli et al, 1990; Rajagopalan et al, 1990; Rajagopalan
et al, 1992). A recent investigation (Desai-Mehta et al, 1995) demon-
strated that anti-DNA autoantibody-inducing Th cells use the restricted
TCR Vα gene (Vα8) and the heterogeneous Vβ gene. In contrast,
little is known about the phenotype and function of T cells infiltrating
into various organs such as skin, kidney, lung, and other tissues. This
study focused on T cells in the skin lesions of SLE patients and the
characteristics and TCR of these cells were analyzed. We obtained
evidence that the majority of T cells in the skin are CD41 T cells and
that their TCR Vβ repertoire is not restricted. SSCP analysis indicates
that they accumulate clonally, suggesting antigen-driven stimulation.
These observations strongly support the notion that T cells in the skin
are not stimulated by a superantigen but by certain antigens through
TCR/MHC.
Dunn et al (1993) reported that based on PCR-Southern blot
analysis, TCR Vβ1, Vβ7, Vβ14, and Vβ16 are often highly expressed
in normal skin. They suggested that the TCR repertoire of skin
lymphocytes is not determined by random sampling of peripheral
blood mononuclear cells but may be molded by an interaction with
self antigens and/or the normal microbial flora in the microenvironment
of the skin. In contrast to normal skin, TCR in SLE skin are
heterogeneous with no preferential expression of TCR Vβ1, Vβ7,
Vβ14, or Vβ16 genes seen in our present study. These results indicate
that T cells infiltrating the skin of SLE recognize different antigens
from normal skin. Tanaka et al (1996) analyzed clonotype of T cells
infiltrating the skin of patients with atopic dermatitis. They detected
oligoclonal accumulation of T cells in the inflamed skin area of patients
with atopic dermatitis using SSCP analysis. They sequenced TCR
genes of T cells infiltrating the skin of atopic dermatitis; however,
there were no LXG amino acid motif in junctional sequences (Takahama
et al, personal communication). These findings suggest that the LXG
motif in the CDR3 of the TCR Vβ gene is specifically found in the
skin of patients with SLE.
TCR on Th cells that induce pathogenic anti-DNA autoantibodies
have been shown to display a recurrent motif of highly charged residues
in their CDR3 loops that are contributed by N-nucleotide addition
(Desai-Mehta et al, 1995). These Th cells in lupus patients respond to
charged epitopes in various DNA-binding nucleoproteins, such as high
mobility group chromosomal protein or nucleosomal histone proteins
(Desai-Mehta et al, 1995). In contrast, we found a highly conserved
LXG amino acid motif at position 96–98 in the CDR3 of skin-specific
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Table III. Junctional sequences of TCR b genes of skin-specific T cells from patients with SLEa
Patient Clone V N-D-N J Jβ
95 106
LE-1 Vβ 4–1 L C S V D Q G V G Vb T E A F F G Jβ1.1
Vβ 4–2 L C S V P S G I G Y N E Q F F G Jβ2.1
Vβ 4–3 L C S V P R D T Y N E Q F F G Jβ2.1
Vβ 4–4 L C S V E G P S G I Y N E Q F F G Jβ2.1
Vβ 4–5 L C S A G L A G A Ec,d E T Q Y F G Jβ2.5
Vβ 4–6 L C S A T G A P V K E Q Y F G Jβ2.7
Vβ 5–1 L C A S S L R G G S T D T Q Y F G Jβ2.3
Vβ 5–2 L C A S S S Q G A T T D T Q Y F G Jβ2.3
Vβ 5–3 L C A S S L A G G P S D T Q Y F G Jβ2.3
Vβ 5–4 L C A S S R T S G R L G D T Q Y F G Jβ2.3
Vβ 5–5 L C A S S L Q G A T T D T Q Y F G Jβ2.3
Vβ 5–6 L C A S S F L A V G P G G D T Q Y F G Jβ2.3
Vβ 5–7 L C A S S H R D R G T Y E Q Y F G Jβ2.7
Vβ13–1 F C A S S D E W T G N Q P Q H F G Jβ1.5
Vβ13–2 F C A S S H R G Q N E R F F G Jβ2.1
Vβ13–3 F C A S R L S G T N H N E Q F F G Jβ2.1
Vβ13–4 F C A S R L A L S T D T Q Y F G Jβ2.3
Vβ13–5 F C A S S D S S A Y E Q Y F G Jβ2.7
Vβ19–1 L C A T Y A V D W G Q G C D E Q F F G Jβ2.1
Vβ19–2 L C A S S S R A T G R N T G E L F F G Jβ2.2
Vβ19–3 L C A R P T Y P S T D T Q Y F G Jβ2.3
LE-2 Vβ 2–1 I C S A T S N R G A A G E L F F G Jβ2.2
Vβ 2–2 I C S A N E G G E Q Y F G Jβ2.7
Vβ 7–1 L C A S S Q D Q H P E A F F G Jβ1.1
Vβ 7–2 L C A S S Q G I E Q F F G Jβ2.1
Vβ 7–3 L C A T H C E G M S T D T Q Y F G Jβ2.3
Vβ 7–4 L C A T H E E G T S G F S T Q Y F G Jβ2.3
Vβ13 F C A S S F R S Q Y T G A N T E A F F G Jβ1.1
Vβ15 F C A T K D S R A G E L F F G Jβ2.2
Vβ17–1 L C A S S I W P S G H E Q Y F G Jβ2.1
Vβ17–2 L C A S S R R E V Y E Q Y F G Jβ2.7
LE-3 Vβ 2–1 I C S A IQ G P P S Y E Q Y F G Jβ2.7
Vβ 2–2 I C S A R G Q P G E Q Y F G Jβ2.7
Vβ 4–1 L C S V E G G T S T D T Q Y F G Jβ2.3
Vβ 4–2 L C S A K E E T Q Y F G Jβ2.5
Vβ 6 L C A S S L A S V Q V T Y N E Q F F G Jβ2.1
Vβ 8–1 F C A S S Q G P D N S P L H F G Jβ1.6
Vβ 8–2 F C A S R G T D T Q Y F G Jβ2.3
Vβ13 F C A S S R L A D E E T Q Y F G Jβ2.5
LE-4 Vβ 2–1 I C S A R D E S S Y N E Q F F G Jβ2.1
Vβ 2–2 I C S A R G L A G A N E Q F F G Jβ2.1
Vβ 2–3 I C S A R D R E S D T Q Y F G Jβ2.3
Vβ 2–4 I C S A I R G P P S Y E Q Y F G Jβ2.7
Vβ 5–1 L C A S S L R G R S T D T Q Y F G Jβ2.3
Vβ 5–2 L C A T A L G G G R A D T Q Y F G Jβ2.3
Vβ 6–1 L C A S S L T S G D T E A F F G Jβ1.1
Vβ 6–2 L C A S S L A S A H V T Y N E Q F F G Jβ2.1
Vβ 6–3 L C A S S L T A G G L G D T Q Y F G Jβ2.3
Vβ 6–4 L C A S S L T T G A G T D T Q Y F G Jβ2.3
Vβ 6–5 L C A S S S G A G G G D T Q Y F G Jβ2.3
Vβ13–1 F C A S S Y S A V L N G E L F F G Jβ2.2
Vβ13–2 F C A S R F A L S T D T Q Y F G Jβ2.3
a The single letter amino acid sequences at the 39 position of TCR Vβ, CDR3, and the 59 position of the J region are given.
b Leucines (L) at position 96 or 97 are in bold type.
c Amino acids encoded by Dβ genes are in italic letters.
d LXG amino acid sequence motifs at position 96–98 in the CDR3 are underlined.
T cells; no recurrent motif of highly charged residues was detected.
This indicates that T cells infiltrating into the skin of SLE patients
recognize limited epitopes on antigens that are different from DNA-
binding nucleoproteins. The LXG amino acid motif was found in two
of four SLE patients. The difference in the conserved amino acids in
the CDR3 region from patient to patient may be due to the presentation
of distinct peptides on different HLA. Indeed, the HLA-DRw52
(DRB3*0202) haplotype was found in both LE-1 and LE-4, although
it was not present in LE-2 or LE-3. From these results, it appears
possible that the LXG amino acid sequence motif and the leucine at
position 96 or 97 are associated peptides present on the DRB3*0202
allele.
An LXG amino acid sequence motif has also been found on TCR
Vβ5.2 T cells in brain lesions of patients with multiple sclerosis
(Oksenberg et al, 1993). The same conserved motif was detected in
the CDR3 region of TCR Vβ5.2 T cells, which are specific for myelin
basic protein (MBP) peptide 89–106 (Martin et al, 1991). It is possible
that T cells in the skin of SLE patients recognize an amino acid
sequence similar to MBP peptide residues 89–106 present on HLA;
however, no common HLA haplotypes can be found between published
multiple sclerosis patients and the SLE patients in this study. Whereas
the LXG motif in multiple sclerosis patients seems to be associated
with HLA DRB1*1501, DQB1*0602, DPB1*0401 (Martin et al,
1991), these alleles are not found in the two SLE patients (LE-1 and
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LE-4) showing the LXG motif in the CDR3. Therefore, not only
peptides homologous to MBP but also peptides unrelated to MBP
might be candidates for the autoantigens recognized by auto-reactive
T cells in the skin lesions of SLE patients.
Although the identity of the autoantigens recognized by auto-
reactive T cells in SLE patients is not clear, there are some reports of
candidate autoantigens. Crow et al (1994) reported that ribosomal P2
protein-specific Th cells are present in blood from patients with SLE.
Desai-Mehta et al (1995) established T cell lines inducing anti-DNA
antibodies from PBL of SLE patients and these cells respond to either
the nonhistone chromosomal protein high mobility group or to
nucleosomal histone proteins. Like human autoimmune diseases,
autoantibody-inducing T cells react with nucleosomes such as DNA
and histone from lupus-prone mice and their CDR3 loops of the
TCR β chains contain a recurrent motif of anionic residues; however,
there have been no reports of autoantigens recognized by T cells
infiltrating the skin lesions of SLE patients.
In conclusion, T cells that infiltrate into the skin of SLE patients
might expand by antigen-driven stimulation and recognize a relatively
limited epitope. An analysis of the ligands recognized by these auto-
reactive T cells should shed light on the mechanisms involved in the
generation of skin lesions in SLE patients.
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